Company Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 17/06/2025 BST			5-day change	1st Jan Change
154.10 ^USD	-3.23%		-0.03%	-21.58%

11:19am	Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating	MT
06-11	IQVIA Launches New AI Agents for Life Sciences and Healthcare	CI

Business description: Iqvia Holdings Inc.

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:

- development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;

- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;

- integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.

Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).

Number of employees: 89,000

Sales by Activity: Iqvia Holdings Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
Research & Development Solutions	5.76B	7.56B	7.92B	8.4B	8.53B
Technology & Analytics Solutions (TAS)	4.86B	5.53B	5.75B	5.86B	6.16B
Contract Sales & Medical Solutions (CSMS)	741M	784M	743M	727M	718M

See all business segments

Geographical breakdown of sales: Iqvia Holdings Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
United States	3.98B	4.72B	6.05B	6.74B	6.47B
Europe and Africa	-	4.36B	4.37B	4.46B	4.92B
Asia-Pacific	2.24B	2.67B	3B	2.97B	3.13B
Americas (Excl. United States)	1.44B	2.13B	996M	809M	886M
Europe and Africa (Excl. United Kingdom)	2.56B	-	-	-	-
United Kingdom	1.14B	-	-	-	-

See all geographic segments

Executive Committee: Iqvia Holdings Inc.

Manager	Title	Age	Since
Ari Bousbib CEO	Chief Executive Officer	64	02/10/2016
Ronald Bruehlman DFI	Director of Finance/CFO	64	31/07/2020
Jeffrey Spaeder CTO	Chief Tech/Sci/R&D Officer	-	-
James Berkshire COO	Chief Operating Officer	52	30/06/2017
W. Staub CTO	Chief Tech/Sci/R&D Officer	62	24/09/2023

See IQVIA HOLDINGS INC. governance

Composition of the Board of Directors: Iqvia Holdings Inc.

Director	Title	Age	Since
John Leonard BRD	Director/Board Member	67	04/02/2015
John Connaughton BRD	Director/Board Member	59	31/12/2007
Ari Bousbib CHM	Chairman	64	02/10/2016
Todd Sisitsky BRD	Director/Board Member	53	31/12/2015
John Danhakl BRD	Director/Board Member	68	02/10/2016
Jim Fasano BRD	Director/Board Member	55	02/10/2016
Colleen Goggins BRD	Director/Board Member	69	26/07/2017
Carol Burt BRD	Director/Board Member	67	20/02/2019
Leslie Morris BRD	Director/Board Member	54	23/01/2022
Sheila Stamps BRD	Director/Board Member	67	25/01/2022

Composition of the Board of Directors

Shareholders: Iqvia Holdings Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 11.27 %	19,838,315	11.27 %	2 784 M $
BlackRock Advisors LLC 6.422 %	11,309,895	6.422 %	1 587 M $
Harris Associates LP 6.343 %	11,169,383	6.343 %	1 567 M $
STATE STREET CORPORATION 4.386 %	7,723,208	4.386 %	1 084 M $
GIC Pte Ltd. (Investment Management) 3.715 %	6,541,387	3.715 %	918 M $

List of IQVIA HOLDINGS INC. shareholders

Company details: Iqvia Holdings Inc.

IQVIA Holdings, Inc.

2400 Ellis Road

27703, Durham

+919 998 2000

http://www.iqvia.com

Group companies: Iqvia Holdings Inc.

Name	Category and Sector
IQVIA Consulting & Information Services India Pvt Ltd. IQVIA Consulting & Information Services India Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2003, IQVIA Consulting & Information Services India Pvt Ltd. is a subsidiary of IQVIA, Inc. that provides consultancy services for the pharmaceutical sector. The company is based in Mumbai, India.	Miscellaneous Commercial Services
IQVIA RDS Italy Srl IQVIA RDS Italy Srl Miscellaneous Commercial ServicesCommercial Services Part of IQVIA Holdings, Inc., IQVIA RDS Italy Srl is a company based in Milan, Italy that offers comprehensive and flexible solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients faster. The Italian company provides innovative pharmacovigilance solutions powered by the IQVIA core, which includes integrated, scalable technologies combined with data, advanced analytics, and deep domain expertise. The company's solutions include dynamic monitoring of structured and unstructured data, single platform source data verification, enablement of decentralized trials, intuitive and automated functionality to improve data quality, audit-ready clinical trials, stronger partnerships between subjects, sites, and sponsors, and interoperable solutions that connect with internal systems and their suite of products. Additionally, IQVIA RDS Italy offers expertise across the generics lifecycle to navigate the complex patent landscape and maximize opportunity.	Miscellaneous Commercial Services
IMS Software Services Ltd.
IQVIA AG (Basal Branch) IQVIA AG (Basal Branch) Data Processing ServicesTechnology Services Part of IQVIA Holdings, Inc., IQVIA AG (Basal Branch) provides data collection and utilization services. The company is based in Cham, Switzerland.	Data Processing Services
IMS HEALTH, INC.	Packaged Software

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
IQVIA HOLDINGS INC.	-3.23%	-0.03%	-27.76%	-21.56%	27.55B
LONZA GROUP AG	-1.27%	-2.91%	+18.40%	+14.81%	49.38B
CELLTRION, INC.	+0.62%	+3.17%	-3.66%	+20.89%	26.36B
EUROFINS SCIENTIFIC SE	-0.98%	+3.59%	+15.24%	-20.52%	12.75B
TEMPUS AI, INC.	-2.62%	+4.74%	+92.19%	-	12.46B
ICON PUBLIC LIMITED COMPANY	-3.52%	+1.54%	-55.16%	-28.10%	11.68B
MODERNA, INC.	-1.73%	-9.20%	-81.47%	-78.90%	10.06B
ASCENDIS PHARMA A/S	-2.71%	-0.14%	+38.78%	+119.97%	10.73B
QIAGEN N.V.	-1.90%	+0.82%	+3.49%	+0.83%	10.28B
MEDPACE HOLDINGS, INC.	-1.02%	-0.13%	-24.76%	+125.24%	8.65B
Average	-1.86%	+1.89%	-2.47%	+14.74%	17.99B
Weighted average by Cap.	-1.62%	+1.33%	+0.92%	+10.06%